John Meshki

596 total citations
18 papers, 475 citations indexed

About

John Meshki is a scholar working on Molecular Biology, Immunology and Virology. According to data from OpenAlex, John Meshki has authored 18 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Immunology and 4 papers in Virology. Recurrent topics in John Meshki's work include HIV Research and Treatment (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Receptor Mechanisms and Signaling (4 papers). John Meshki is often cited by papers focused on HIV Research and Treatment (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Receptor Mechanisms and Signaling (4 papers). John Meshki collaborates with scholars based in United States, Romania and Italy. John Meshki's co-authors include Florin Tuluc, Steven D. Douglas, Satya P. Kunapuli, Marcelo G. Kazanietz, M. Cecilia Caino, Sergei Spitsin, Lynnae Schwartz, Jianping Lai, Zhongren Ding and Laurie E. Kilpatrick and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cell Reports.

In The Last Decade

John Meshki

18 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Meshki United States 12 254 105 96 64 63 18 475
Sophie Foppolo France 10 289 1.1× 81 0.8× 58 0.6× 124 1.9× 239 3.8× 17 672
Mária Magócsi Hungary 18 351 1.4× 61 0.6× 96 1.0× 182 2.8× 52 0.8× 25 715
Jean-Marie Vanderwinden Belgium 9 243 1.0× 68 0.6× 114 1.2× 81 1.3× 17 0.3× 15 601
Eduard Gracia Spain 8 205 0.8× 79 0.8× 90 0.9× 66 1.0× 248 3.9× 16 472
Andrea Šoltýsová Slovakia 14 354 1.4× 28 0.3× 49 0.5× 116 1.8× 18 0.3× 37 624
Chen Luo China 15 319 1.3× 24 0.2× 65 0.7× 103 1.6× 53 0.8× 39 553
Martin Krenn Austria 13 135 0.5× 86 0.8× 36 0.4× 22 0.3× 18 0.3× 36 394
Michal Šmída Czechia 12 291 1.1× 71 0.7× 181 1.9× 184 2.9× 9 0.1× 23 626
Iris K. Madera‐Salcedo Mexico 13 172 0.7× 50 0.5× 290 3.0× 54 0.8× 13 0.2× 18 501
Eleonora Piras Italy 10 277 1.1× 40 0.4× 105 1.1× 126 2.0× 51 0.8× 13 597

Countries citing papers authored by John Meshki

Since Specialization
Citations

This map shows the geographic impact of John Meshki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Meshki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Meshki more than expected).

Fields of papers citing papers by John Meshki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Meshki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Meshki. The network helps show where John Meshki may publish in the future.

Co-authorship network of co-authors of John Meshki

This figure shows the co-authorship network connecting the top 25 collaborators of John Meshki. A scholar is included among the top collaborators of John Meshki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Meshki. John Meshki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Vaira, Valentina, Alessandro Del Gobbo, A. Palleschi, et al.. (2024). MIRO2 promotes cancer invasion and metastasis via MYO9B suppression of RhoA activity. Cell Reports. 44(1). 115120–115120. 1 indexed citations
2.
Spitsin, Sergei, John Meshki, Angela Winters, et al.. (2016). Substance P–mediated chemokine production promotes monocyte migration. Journal of Leukocyte Biology. 101(4). 967–973. 30 indexed citations
3.
Tuluc, Florin, John Meshki, Sergei Spitsin, & Steven D. Douglas. (2014). HIV infection of macrophages is enhanced in the presence of increased expression of CD163 induced by substance P. Journal of Leukocyte Biology. 96(1). 143–150. 26 indexed citations
4.
Spitsin, Sergei, Florin Tuluc, John Meshki, et al.. (2013). Analog of Somatostatin Vapreotide Exhibits Biological Effects in vitro via Interaction with Neurokinin-1 Receptor. NeuroImmunoModulation. 20(5). 247–255. 7 indexed citations
5.
Schwartz, Lynnae, Sergei Spitsin, John Meshki, et al.. (2013). Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor. Journal of NeuroVirology. 19(3). 219–227. 5 indexed citations
6.
Chen, Panpan, Steven D. Douglas, John Meshki, & Florin Tuluc. (2012). Neurokinin 1 Receptor Mediates Membrane Blebbing and Sheer Stress-Induced Microparticle Formation in HEK293 Cells. PLoS ONE. 7(9). e45322–e45322. 14 indexed citations
7.
Meshki, John, Steven D. Douglas, Mingyue Hu, Susan E. Leeman, & Florin Tuluc. (2011). Substance P Induces Rapid and Transient Membrane Blebbing in U373MG Cells in a p21-Activated Kinase-Dependent Manner. PLoS ONE. 6(9). e25332–e25332. 35 indexed citations
8.
Meshki, John, et al.. (2010). Regulation of Prostate Cancer Cell Survival by Protein Kinase C∈ Involves Bad Phosphorylation and Modulation of the TNFα/JNK Pathway. Journal of Biological Chemistry. 285(34). 26033–26040. 37 indexed citations
9.
Manak, Mark, Dmitry Moshkoff, John Meshki, et al.. (2010). Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals. AIDS. 24(18). 2789–2796. 25 indexed citations
10.
Meshki, John, Steven D. Douglas, Jianping Lai, et al.. (2009). Neurokinin 1 Receptor Mediates Membrane Blebbing in HEK293 Cells through a Rho/Rho-associated Coiled-coil Kinase-dependent Mechanism. Journal of Biological Chemistry. 284(14). 9280–9289. 67 indexed citations
11.
Caino, M. Cecilia, John Meshki, & Marcelo G. Kazanietz. (2009). Hallmarks for senescence in carcinogenesis: novel signaling players. APOPTOSIS. 14(4). 392–408. 33 indexed citations
12.
Meshki, John, et al.. (2006). Signaling pathways downstream of P2 receptors in human neutrophils. Purinergic Signalling. 2(3). 537–544. 10 indexed citations
13.
Meshki, John, et al.. (2006). [Functional characteristics of nucleotide-receptors in human neutrophils].. PubMed. 109(1). 191–9. 1 indexed citations
14.
Tuluc, Florin, Eugen Brailoiu, John Meshki, et al.. (2005). The priming effect of extracellular UTP on human neutrophils: Role of calcium released from thapsigargin-sensitive intracellular stores. Purinergic Signalling. 1(4). 359–68. 10 indexed citations
15.
González-Guerrico, Anatilde M., John Meshki, Liqing Xiao, et al.. (2005). Molecular Mechanisms of Protein Kinase C-induced Apoptosis in Prostate Cancer Cells. BMB Reports. 38(6). 639–645. 49 indexed citations
16.
Tuluc, Florin, et al.. (2004). Primary granule release from human neutrophils is potentiated by soluble fibrinogen through a mechanism depending on multiple intracellular signaling pathways. American Journal of Physiology-Cell Physiology. 287(5). C1264–C1272. 31 indexed citations
17.
Meshki, John, et al.. (2004). Molecular mechanism of nucleotide-induced primary granule release in human neutrophils: role for the P2Y2 receptor. American Journal of Physiology-Cell Physiology. 286(2). C264–C271. 62 indexed citations
18.
Tuluc, Florin, John Meshki, & Satya P. Kunapuli. (2003). Membrane lipid microdomains differentially regulate intracellular signaling events in human neutrophils. International Immunopharmacology. 3(13-14). 1775–1790. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophie Foppolo Breakdown of academic impact, for papers by Mária Magócsi Breakdown of academic impact, for papers by Jean-Marie Vanderwinden Breakdown of academic impact, for papers by Eduard Gracia Breakdown of academic impact, for papers by Andrea Šoltýsová Breakdown of academic impact, for papers by Chen Luo Breakdown of academic impact, for papers by Martin Krenn Breakdown of academic impact, for papers by Michal Šmída Breakdown of academic impact, for papers by Iris K. Madera‐Salcedo Breakdown of academic impact, for papers by Eleonora Piras
Rankless by CCL
2026